Search - tctmd.com

Displaying 1 - 20 of 310

Sort: Relevancy | Date

Presentation TCT 2025

Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation: Technology Update, Human Experience and Imaging Insights

Presenter: Susheel K. Kodali

October 28, 2025

Presentation TCT 2025

The TRISCEND II Trial: Practice-Changing Implications

Presenter: Susheel K. Kodali

October 26, 2025

Presentation TCT 2025

Considerations for Device Selection in M-TEER: Matching Anatomy with Technology

Presenter: Susheel K. Kodali

October 26, 2025

Presentation TCT India 2025

Percutaneous axillary access and closure: Step by Step

Presenter: Susheel Kodali

July 26, 2025

$Role of fracture during valve in valve - When and How to do?$

Presentation TCT India 2025

Role of fracture during valve in valve - When and How to do?

Presenter: Susheel Kodali

July 25, 2025

Presentation NY Valves 2025

Novel Balloon-Expandable Transcatheter Heart Valve for Aortic Stenosis: Insights from the First-In-Human Series (Abbott)

Presenter: Susheel K. Kodali

June 26, 2025

Presentation NY Valves 2025

Presentation 1: Encantor TAVR

Presenter: Susheel K. Kodali

June 26, 2025

Presentation NY Valves 2025

Patient Selection for TTVR: Clinical/Physiologic Considerations

Presenter: Susheel K. Kodali

June 26, 2025

Presentation NY Valves 2025

Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Mitral Regurgitation (Nyra)

Presenter: Susheel K. Kodali

June 26, 2025

Presentation Fellows 2025

The Structural Heart Revolution: Perspectives From Fellowship and Beyond

Presenter: Susheel K. Kodali

May 17, 2025

Presentation Fellows 2025

The TAVR Journey and Remaining Unmet Needs

Presenter: Susheel K. Kodali

May 17, 2025

News Conference News TCT 2024

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

Yael L. Maxwell

October 30, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

How to Manage After TTVI?

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Role of Advanced Imaging Guidance by AI-Based Device Intelligence

Presenter: Susheel Kodali

October 29, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

Presenter: Susheel K. Kodali

June 07, 2024

Presentation NY Valves 2024

Report of an IDE Pivotal Study of a Dedicated Leaflet Splitting Device During TAVR (SHORTCUT)

Presenter: Susheel K. Kodali

June 07, 2024

Presentation NY Valves 2024

Post-Market Considerations: How Can We Ensure Rational Diffusion of TTVI, Optimal Training and Maintenance of Quality?

Presenter: Susheel K. Kodali

June 06, 2024

Presentation NY Valves 2024

TRISCEND II: Understanding the Study Design and Interpreting the Results

Presenter: Susheel K. Kodali

June 06, 2024

Advertisement

Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation: Technology Update, Human Experience and Imaging Insights

The TRISCEND II Trial: Practice-Changing Implications

Considerations for Device Selection in M-TEER: Matching Anatomy with Technology

Percutaneous axillary access and closure: Step by Step

Role of fracture during valve in valve - When and How to do?

Novel Balloon-Expandable Transcatheter Heart Valve for Aortic Stenosis: Insights from the First-In-Human Series (Abbott)

Presentation 1: Encantor TAVR

Patient Selection for TTVR: Clinical/Physiologic Considerations

Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Mitral Regurgitation (Nyra)

The Structural Heart Revolution: Perspectives From Fellowship and Beyond

The TAVR Journey and Remaining Unmet Needs

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

How to Manage After TTVI?

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Role of Advanced Imaging Guidance by AI-Based Device Intelligence

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

Report of an IDE Pivotal Study of a Dedicated Leaflet Splitting Device During TAVR (SHORTCUT)

Post-Market Considerations: How Can We Ensure Rational Diffusion of TTVI, Optimal Training and Maintenance of Quality?

TRISCEND II: Understanding the Study Design and Interpreting the Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content